HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

The Thymes: Launch of Everyday Essentials Foot Care will be supported with roughly 10,000 samples, firm says. Company's first foot care offerings include Restorative Foot Soak ($16), an Epson salt blend that "reduces swelling, eases aches and neutralizes odor" and Smoothing Foot Scrub ($18), which contains ground walnut shells and pumice to exfoliate and vitamin E, glycerin and sunflower seed to protect and moisturize, firm says. Multi-Action Foot Care ($18) uses alpha hydroxy acids and humectants to exfoliate and shea butter jojoba oil to moisturize. The Thymes will seek to launch the line in its 5,000-door specialty store distribution. The company introduced Everyday Essentials Face Care last summer, positioned as a range that "supercharges" skin care without adding extra steps to the regime. The Thymes reported sales of $40 mil. in fiscal 2003...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS011887

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel